,

–

Mackness, M.I., Arrol, S., Abbott, C.A., Durrington, P.N.,

lipoprotein associated paraoxonase. Atherosclerosis

,

–

Mackness, M.I., Arrol, S., Mackness, B., Durrington, P.N., Alloenzymes of paraoxonase and effectiveness of lipoproteins in protecting low-density lipoprotein against peroxidation. Lancet

,

–

Mackness, B., Mackness, M.I., Arrol, S., Turkie, W., Durrington,

b. Effect of the molecular polymorphisms of human PON

on the rate of hydrolysis of paraxon. Br. J. Pharmacol.

–

Mackness, B., Mackness, M.I., Arrol, S., Turkie, W., Durrington,

Effect of the human serum paraoxonase

and

polymorphisms on the protection by high density lipoprotein low density lipoprotein oxidative modification. FEBS Lett.

, Mackness, B., Davies, G.K., Turkie, W., Lee, E., Roberts, D.H., Hill, Roberts, C., Durrington, P.N., Mackness, M.I.,

Paraxonase in coronary heart disease. Atheroscl. Thromb. Vasc. Biol.

–

Mackness, B., Durrington, P., M

lduff, P., Yarnell, J., Azam, N., M., Mackness, M.,

Low paraxonase activity predicts